Skip to content
The Policy VaultThe Policy Vault

Targretin — Medica

cutaneous T-cell lymphoma

Initial criteria

  • Patient has cutaneous manifestations/lesions
  • Medication is prescribed by or in consultation with an oncologist or a dermatologist

Approval duration

1 year